Literature DB >> 26891937

Peripheral activities of growth hormone-releasing hormone.

R Granata1.   

Abstract

Growth hormone (GH)-releasing hormone (GHRH) is produced by the hypothalamus and stimulates GH synthesis and release in the anterior pituitary gland. In addition to its endocrine role, GHRH exerts a wide range of extrapituitary effects which include stimulation of cell proliferation, survival and differentiation, and inhibition of apoptosis. Accordingly, expression of GHRH, as well as the receptor GHRH-R and its splice variants, has been demonstrated in different peripheral tissues and cell types. Among the direct peripheral activities, GHRH regulates pancreatic islet and β-cell survival and function and endometrial cell proliferation, promotes cardioprotection and wound healing, influences the immune and reproductive systems, reduces inflammation, indirectly increases lifespan and adiposity and acts on skeletal muscle cells to inhibit cell death and atrophy. Therefore, it is becoming increasingly clear that GHRH exerts important extrapituitary functions, suggesting potential therapeutic use of the peptide and its analogs in a wide range of medical settings.

Entities:  

Keywords:  GHRH agonists and antagonists; Growth hormone-releasing hormone (GHRH)

Mesh:

Substances:

Year:  2016        PMID: 26891937     DOI: 10.1007/s40618-016-0440-x

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  57 in total

Review 1.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

2.  Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice.

Authors:  Xianyang Zhang; Tengjiao Cui; Jinlin He; Haibo Wang; Renzhi Cai; Petra Popovics; Irving Vidaurre; Wei Sha; Janine Schmid; Barbara Ludwig; Norman L Block; Stefan R Bornstein; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-16       Impact factor: 11.205

3.  Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.

Authors:  Victoria Florea; Sonia S Majid; Rosemeire M Kanashiro-Takeuchi; Ren-Zhi Cai; Norman L Block; Andrew V Schally; Joshua M Hare; Claudia O Rodrigues
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

4.  Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.

Authors:  Shane R Cunha; Kelly E Mayo
Journal:  Endocrinology       Date:  2002-12       Impact factor: 4.736

5.  GHRH proliferative action on somatotrophs is cell-type specific and dependent on Pit-1/GHF-1 expression.

Authors:  A Solloso; L Barreiro; R Seoane; E Nogueira; C Cañibano; C V Alvarez; J Zalvide; C Diéguez; C M Pombo
Journal:  J Cell Physiol       Date:  2008-04       Impact factor: 6.384

6.  Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.

Authors:  Laura D Baker; Suzanne M Barsness; Soo Borson; George R Merriam; Seth D Friedman; Suzanne Craft; Michael V Vitiello
Journal:  Arch Neurol       Date:  2012-11

Review 7.  Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.

Authors:  Andrew V Schally; Jozsef L Varga; Jörg B Engel
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-01

8.  Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.

Authors:  Renzhi Cai; Andrew V Schally; Tengjiao Cui; Luca Szalontay; Gabor Halmos; Wei Sha; Magdolna Kovacs; Miklos Jaszberenyi; Jinlin He; Ferenc G Rick; Petra Popovics; Rosemeire Kanashiro-Takeuchi; Joshua M Hare; Norman L Block; Marta Zarandi
Journal:  Peptides       Date:  2013-12-25       Impact factor: 3.750

9.  New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.

Authors:  Rosemeire M Kanashiro-Takeuchi; Luca Szalontay; Andrew V Schally; Lauro M Takeuchi; Petra Popovics; Miklos Jaszberenyi; Irving Vidaurre; Marta Zarandi; Ren-Zhi Cai; Norman L Block; Joshua M Hare; Ferenc G Rick
Journal:  Oncotarget       Date:  2015

10.  Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice.

Authors:  Liou Y Sun; Adam Spong; William R Swindell; Yimin Fang; Cristal Hill; Joshua A Huber; Jacob D Boehm; Reyhan Westbrook; Roberto Salvatori; Andrzej Bartke
Journal:  Elife       Date:  2013-10-29       Impact factor: 8.140

View more
  10 in total

Review 1.  Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age.

Authors:  Silvana Duran-Ortiz; Edward O List; Reetobrata Basu; John J Kopchick
Journal:  Pituitary       Date:  2021-01-18       Impact factor: 4.107

Review 2.  Growth Hormone-Releasing Hormone in Diabetes.

Authors:  Leonid E Fridlyand; Natalia A Tamarina; Andrew V Schally; Louis H Philipson
Journal:  Front Endocrinol (Lausanne)       Date:  2016-10-10       Impact factor: 5.555

3.  Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy.

Authors:  Menaka C Thounaojam; Folami L Powell; Sagar Patel; Diana R Gutsaeva; Amany Tawfik; Sylvia B Smith; Julian Nussbaum; Norman L Block; Pamela M Martin; Andrew V Schally; Manuela Bartoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-27       Impact factor: 12.779

4.  Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.

Authors:  Tania Villanova; Iacopo Gesmundo; Valentina Audrito; Nicoletta Vitale; Francesca Silvagno; Chiara Musuraca; Luisella Righi; Roberta Libener; Chiara Riganti; Paolo Bironzo; Silvia Deaglio; Mauro Papotti; Renzhi Cai; Wei Sha; Ezio Ghigo; Andrew V Schally; Riccarda Granata
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-18       Impact factor: 11.205

5.  Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice.

Authors:  Lucia Recinella; Annalisa Chiavaroli; Valentina Di Valerio; Serena Veschi; Giustino Orlando; Claudio Ferrante; Iacopo Gesmundo; Riccarda Granata; Renzhi Cai; Wei Sha; Andrew V Schally; Rossano Lattanzio; Luigi Brunetti; Sheila Leone
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

6.  Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma.

Authors:  Iacopo Gesmundo; Francesca Pedrolli; Nicoletta Vitale; Alessia Bertoldo; Giulia Orlando; Dana Banfi; Giuseppina Granato; Ramesh Kasarla; Federico Balzola; Silvia Deaglio; Renzhi Cai; Wei Sha; Mauro Papotti; Ezio Ghigo; Andrew V Schally; Riccarda Granata
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

7.  Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.

Authors:  Iacopo Gesmundo; Michele Miragoli; Pierluigi Carullo; Letizia Trovato; Veronica Larcher; Elisa Di Pasquale; Mara Brancaccio; Marta Mazzola; Tania Villanova; Matteo Sorge; Marina Taliano; Maria Pia Gallo; Giuseppe Alloatti; Claudia Penna; Joshua M Hare; Ezio Ghigo; Andrew V Schally; Gianluigi Condorelli; Riccarda Granata
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-25       Impact factor: 11.205

8.  Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice.

Authors:  Lucia Recinella; Annalisa Chiavaroli; Giustino Orlando; Claudio Ferrante; Guya Diletta Marconi; Iacopo Gesmundo; Riccarda Granata; Renzhi Cai; Wei Sha; Andrew V Schally; Luigi Brunetti; Sheila Leone
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

9.  Effect of growth hormone releasing hormone on chondrocytes of osteoarthritis.

Authors:  Zhuoran Li; Yao Li
Journal:  Korean J Intern Med       Date:  2019-12-26       Impact factor: 2.884

Review 10.  Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease.

Authors:  Julia M Fraile; Soumya Palliyil; Caroline Barelle; Andrew J Porter; Marina Kovaleva
Journal:  Drug Des Devel Ther       Date:  2021-09-22       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.